Sigma Planning Corp Invitae Corp Transaction History

Sigma Planning Corp

$3.16 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$1.2 - $2.73 $600 - $1,365	-500 Reduced 4.66%	10,222 $13,000
Q4 2022 Jan 24, 2023	BUY	$1.71 - $3.61 $51 - $108	30 Added 0.28%	10,722 $0
Q3 2022 Nov 10, 2022	SELL	$1.9 - $8.63 $23,408 - $106,321	-12,320 Reduced 53.54%	10,692 $26,000
Q2 2022 Aug 11, 2022	BUY	$2.13 - $9.01 $49,015 - $207,338	23,012 New	23,012 $56,000
Q1 2022 Apr 20, 2022	SELL	$6.28 - $15.59 $69,098 - $171,536	-11,003 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$14.7 - $28.67 $279,667 - $545,446	-19,025 Reduced 63.36%	11,003 $168,000
Q3 2021 Oct 28, 2021	SELL	$24.31 - $33.6 $22,924 - $31,684	-943 Reduced 3.04%	30,028 $854,000
Q2 2021 Aug 13, 2021	SELL	$26.09 - $40.4 $136,111 - $210,766	-5,217 Reduced 14.42%	30,971 $1.05 Million
Q1 2021 May 06, 2021	BUY	$33.06 - $56.93 $44,333 - $76,343	1,341 Added 3.85%	36,188 $1.38 Million
Q4 2020 Feb 09, 2021	BUY	$39.09 - $57.4 $234,696 - $344,629	6,004 Added 20.82%	34,847 $1.46 Million
Q3 2020 Nov 03, 2020	SELL	$28.43 - $44.67 $184,652 - $290,131	-6,495 Reduced 18.38%	28,843 $1.25 Million
Q2 2020 Jul 31, 2020	BUY	$11.71 - $30.29 $141,433 - $365,842	12,078 Added 51.93%	35,338 $1.07 Million
Q1 2020 May 01, 2020	SELL	$7.64 - $27.5 $145,297 - $522,995	-19,018 Reduced 44.98%	23,260 $318,000
Q4 2019 Feb 03, 2020	BUY	$15.02 - $20.57 $161,600 - $221,312	10,759 Added 34.13%	42,278 $682,000
Q3 2019 Nov 01, 2019	BUY	$18.85 - $27.5 $151,572 - $221,127	8,041 Added 34.25%	31,519 $607,000
Q2 2019 Aug 01, 2019	BUY	$17.37 - $26.27 $132,758 - $200,781	7,643 Added 48.27%	23,478 $552,000
Q1 2019 May 01, 2019	BUY	$10.65 - $25.75 $168,642 - $407,751	15,835 New	15,835 $371,000
Q4 2018 Jan 31, 2019	SELL	$9.26 - $16.38 $139,733 - $247,174	-15,090 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$7.54 - $18.31 $113,778 - $276,297	15,090 New	15,090 $252,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

2.12M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account